Genomtec S.A.
GMT
Rank in Stocks
#28181
Genomtec S.A., established in 2016 and based in Wroclaw, Poland, is dedicated... Genomtec S.A., established in 2016 and based in Wroclaw, Poland, is dedicated to the research, development, manufacturing, and global commercialization of advanced molecular diagnostic products. The company's expertise lies in optical systems and isothermal nucleic acid amplification methodologies. A core offering is Genomtec ID, a portable technological device designed for on-the-go genetic diagnostics. This system employs streamlined nucleic acid amplification technology (SNAAT) to detect viruses, bacteria, fungi, and genetic mutations through the analysis of patient biological materials like swabs, urine, saliva, blood, and other bodily fluids. Furthermore, Genomtec has developed Genomtec Tumor, a SNAAT-based solution for identifying neoplastic mutations and those with prognostic value in cancer diagnoses. The company also offers diagnostic kits for COVID-19, including the Genomtec SARS-CoV-2 EvaGreen and Direct-RT-LAMP CE-IVD Kit, which detects SARS-CoV-2 RNA in samples from individuals suspected of infection, and the Genomtec RT-LAMP CE-IVD Duo-Kit, capable of identifying all variants of the SARS-CoV-2 virus.
Share Price
$0.69413617
Last synced: 2026-11-12
Market Cap
$11.85M
Change (1 day)
2.00%
Change (1 year)
-47.39%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Genomtec S.A. (GMT)
Category
Healthcare
EPS for Genomtec S.A. (GMT)
EPS as of June 2026 TTM: $-0.13
According to Genomtec S.A.'s latest financial reports, its current EPS (TTM) is $-0.13. At the end of 2025 the company had an EPS of $-0.19, an increase over its 2024 EPS of $-0.20.
EPS history for Genomtec S.A. from 2018 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.13 | -30.21% |
| 2025 | $-0.19 | -6.12% |
| 2024 | $-0.20 | 8.55% |
| 2023 | $-0.19 | -35.02% |
| 2022 | $-0.29 | 34.42% |
| 2021 | $-0.22 | -40.03% |
| 2020 | $-0.36 | 660.04% |
| 2019 | $-0.05 | 94.65% |
| 2018 | $-0.02 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $2.70 | -2,136.20% |
US
|
|
| $4.09 | -3,184.46% |
IE
|
|
| $9.45 | -7,226.70% |
US
|
|
| $2.37 | -1,887.33% |
US
|
|
| $1.77 | -1,434.84% |
US
|
Questions about Genomtec S.A.'s earnings per share (EPS)
What is Genomtec S.A.'s earnings per share (EPS)?
Genomtec S.A.'s earnings per share (EPS) over the last twelve months is $-0.13, as of Jun 2026.
What was Genomtec S.A.'s earnings per share (EPS) in 2025?
In 2025, Genomtec S.A.'s earnings per share (EPS) was $-0.19, compared with $-0.20 in 2024.
How has Genomtec S.A.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Genomtec S.A.'s earnings per share (EPS) was highest in 2025 ($-0.19) and lowest in 2020 ($-0.36).
How does Genomtec S.A.'s earnings per share (EPS) compare with similar companies?
Genomtec S.A.'s earnings per share (EPS) ($-0.13) is lower than that of all 5 similar companies listed above. The highest among them is Stryker Corporation, with $9.45.